1De Silyestro G,Rozga J,Podesta L,et al.A single institution's experience(1992-1999)with plasma-exchange therapy in patients with fulminant hepatic failure[J].Int J Artif Organs,2000,23:454.
2Lwai H,Nagaki M,Naito T,et al.Removal of endotoxin and cytokinesy plasma exchange in patients with acute hepatic failure[J].Crit Care Med,1998,26:873-876.
7Kawanish H,Tsushiya T,Hirabagashi A,et al.Liver support system used sorbent urethane sheet embedded with powdered charcoal[J].Biomater Artif Organs,1990,(18)7:535-540.
10Stange J,Mitzner S,Riser T,et al.Molecular absorbent recycling system(MARS):Clinical results of a new membrane-based blood purification system for bioartificial liver support[J].Artif Organs,1999,(23)4:319-330.
二级参考文献48
1陈明亮 刘三都.肝纤维化的基础研究及临床[M].北京:人民出版社,1996.231-245.
2[3]Luster MI, Germolec DR, Yoshida T, et al. Endotoxin induced cytokine gene expression and excretion in the liver. Hepatology, 1994,19:480
3[4]Onji M, Horiike N, Ohta Y. Patterns and pathobiology of hepatic necrosis in chronic viral hepatitis. Gastroenterologia Japonica, 1993,28:26
4[5]Sanchez JA, Perez JL. Cytokines clearence during veno- venous hemofiltration in the trauma patients. Am J Kid Dis, 1997,30:438
5O' Grady JG, Gimson AE,O' Brein CJ, et al. controlled trails of charcoal hemo perfusion and prognostic factors in fulminant hepatic failure [ J ]. Gastroenterology, 1998; 94: 1186 -1192.
6Caos, Esquived co, Keeffe EB. New approaches to supporting the failing liver [ J ]. Annu Med, 1998 ;49: 85 - 84.
7Van de Kerkhove MP, Hoekstra R, Charnuleau RA, et al. Clinical application of bioartificial liver support systems. Ann Surg, 2004, 240(2): 216-230.
8Strain AJ, Neuberger JM. A bioartifieial liver state of the art. Science, 2002, 295 (5557): 1005-1009.
9LiuJP, Kjaergard LL, Als-Nielsen B, et al. Artifieaial and bioartifieial support systems for liver failure; a cochrane hepato-biliary group protocol. Liver, 2002, 22 (5): 433-438.
10Jared W, Tarek H, Sangeeta N. Advances in bioartifieial liver devices. Hepatology, 2001, 34 (3): 447-455.
